Gilead plans to begin Phase 3 testing soon for a drug it believes could prevent HIV infection with a single shot every year ...

But 2024 has fueled increasing optimism among leading infectious disease experts after the results of two groundbreaking ...

The drug called lenacapavir is already sold under the brand name Sunlenca to treat HIV infections in the U.S., Canada, Europe and elsewhere. The company plans to seek authorization soon for ...

Deaths from HIV/AIDS are ten times lower than at the peak of the epidemic, and new research could drive that down even more.

Gilead Sciences’ top money maker Biktarvy has been the company’s crown jewel for years now, but with the HIV med inching ...

Kenya’s ministry of health has approved the nationwide roll out of a vaginal ring to help women protect themselves from HIV.

A collaboration between The Wistar Institute and the University of Buea in Cameroon has uncovered the mechanisms for a ...

In two mid-Michigan school districts where the HIV education curriculum was discovered to be out of date a year ago by 6 News ...

100% of 2134 women aged 16-25 years in South Africa and Uganda who received a twice yearly injection of the drug lenacapavir were protected against HIV. On the other hand, there were 39 infections ...

Baguio City has been averaging seven new HIV cases monthly since January, while Benguet province reports three cases per ...